var | Overall | Missing |
---|---|---|
n | 152 | |
age_event (mean (SD)) | 52.3 (18.0) | 0.0 |
sex = M (%) | 95 (62.5) | 0.0 |
days_icu (mean (SD)) | 45.4 (20.1) | 0.0 |
etiology (%) | 0.0 | |
TBI | 54 (35.5) | |
Vascular | 77 (50.7) | |
Anoxic | 15 (9.9) | |
Infective | 2 (1.3) | |
Neoplastic | 4 (2.6) | |
Mixed | 0 (0.0) | |
isp_icu = yes (%) | 15 (11.2) | 11.8 |
treatment (%) | 0.0 | |
none | 18 (8.1) | |
opioids | 10 (4.5) | |
benzos | 23 (10.4) | |
barbiturate | 6 (2.7) | |
beta_blockers | 70 (31.7) | |
alpha_blockers | 16 (7.2) | |
dopa_antagonist | 3 (1.4) | |
baclofen | 18 (8.1) | |
other | 57 (25.8) |
var | Overall | Missing |
---|---|---|
n | 152 | |
diagnosis (%) | 0.0 | |
Emersion | 39 (25.7) | |
MCS | 54 (35.5) | |
VS | 59 (38.8) | |
crs_r (mean (SD)) | 11.9 (7.1) | 0.7 |
lcf (mean (SD)) | 3.1 (1.3) | 0.0 |
tracheo = yes (%) | 135 (88.8) | 0.0 |
breath (%) | 5.9 | |
Autonomous | 58 (40.6) | |
Autonomous + O2 | 80 (55.9) | |
Mechanical | 5 (3.5) | |
feed (%) | 0.7 | |
Oral | 11 (7.3) | |
Parenteral | 2 (1.3) | |
NG-tube | 63 (41.7) | |
PEG | 75 (49.7) | |
cateth = yes (%) | 147 (96.7) | 0.0 |
bedsore = yes (%) | 55 (36.2) | 0.0 |
fractures = yes (%) | 37 (24.3) | 0.0 |
asworth = yes (%) | 31 (20.4) | 0.0 |
poa = yes (%) | 4 (2.6) | 0.0 |
craniolac = yes (%) | 32 (21.1) | 0.0 |
hydrocef = yes (%) | 15 (9.9) | 0.0 |
erbi_sub_a (mean (SD)) | -177.8 (42.1) | 0.0 |
erbi_sub_b (mean (SD)) | 0.7 (5.4) | 0.0 |
psh_cfs_t0 (mean (SD)) | 3.4 (2.9) | 5.9 |
psh_dlt_t0 (mean (SD)) | 2.7 (2.4) | 5.9 |
psh_tot_t0 (mean (SD)) | 6.8 (5.8) | 0.0 |
psh_tot_t0_cat (%) | 0.7 | |
Unlikely | 104 (68.9) | |
Possible | 31 (20.5) | |
Probable | 16 (10.6) | |
nr_crisis_t0 (%) | 6.6 | |
none | 112 (78.9) | |
<3 | 15 (10.6) | |
3-5 | 14 (9.9) | |
>5 | 1 (0.7) | |
treatment (%) | 0.0 | |
none | 91 (55.8) | |
opioids | 5 (3.1) | |
benzos | 19 (11.7) | |
barbiturate | 0 (0.0) | |
beta_blockers | 25 (15.3) | |
alpha_blockers | 7 (4.3) | |
dopa_antagonist | 0 (0.0) | |
baclofen | 7 (4.3) | |
other | 9 (5.5) |
var | Overall | Missing |
---|---|---|
n | 152 | |
psh_cfs_t1 (mean (SD)) | 2.9 (2.4) | 5.9 |
psh_dlt_t1 (mean (SD)) | 2.5 (2.3) | 5.9 |
psh_tot_t1 (mean (SD)) | 6.1 (5.3) | 0.0 |
psh_tot_t1_cat (%) | 0.0 | |
Unlikely | 115 (75.7) | |
Possible | 24 (15.8) | |
Probable | 13 (8.6) | |
nr_crisis_t1 (%) | 5.9 | |
none | 122 (85.3) | |
<3 | 13 (9.1) | |
3-5 | 8 (5.6) | |
>5 | 0 (0.0) | |
treatment (%) | 0.0 | |
none | 92 (56.4) | |
opioids | 4 (2.5) | |
benzos | 18 (11.0) | |
barbiturate | 0 (0.0) | |
beta_blockers | 25 (15.3) | |
alpha_blockers | 6 (3.7) | |
dopa_antagonist | 0 (0.0) | |
baclofen | 7 (4.3) | |
other | 11 (6.7) |
Figure 1. ICU lenght of stay by patient’s age
Figure 2. Registered treatments per week
Figure 3. Registered treatments at admission by reported ISP crisis in ICU
Figure 4. Registered treatments at week1 and 2 by reported nr. of ISP crisis
Figure 5. CRS-R (A) and LCF (B) by diagnosis
Figure 6. Number of Patients on tracheostomy (A) and assisted ventilation (B) by diagnosis
Figure 7. Number of Patients on assisted feeding (A) and urinary catheterization (B) by diagnosis
Figure 8. Number of Patients with bedsore (A), spasticity (measured by Asworth scale; C), fractures (B) and POA (D) by diagnosis
Figure 8. Number of Patients with Luckenschadel (A) and Hydrocefalus (B) by diagnosis
Figure 9. ERBI subscale A (A) and ERBI subscale B (B) by diagnosis
Figure 10. PSH-AM scale result by nr. of ISP crisis in the first week of rehab
Figure 11. PSH-AM total score by nr. of ISP crisis and treatment in the first week of rehab (numbers indicate subgroup size)